Featured insights The latest at the Foundation Insights from our industry-shifting research and analysis, coverage in the international media, events, and all the latest from the Access to Medicine Foundation. News New 2024 Index Methodology places greater focus on measuring patient reach 10 October 2023 News Five ways to ramp up access to essential diabetes products 27 July 2023 News Spotlight on the generics industry: New analysis looks at access efforts of 5 major companies 26 September 2023 Featured News The 2021 AMR Benchmark pinpointed opportunities for companies. Did they take them? 21 November 2023 Resource Center Explore our research reports and publications Featured News First-of-its-kind framework to assess how generics manufacturers expand access to medicine 15 February 2023 Event Joint event with World Economic Forum on the evolving role of generics – Meeting Report 21 June 2023 News Foundation names Expert Review Committee for 2024 Access to Medicine Index 18 July 2023 Research How companies perform on ensuring access to their SRHR-related products for women and girls in LMICs 25 November 2022 2022 Ranking GSK in top spot, Johnson & Johnson close second. AstraZeneca leaps up to join the top three. Bayer and Merck climb the Index ranking. Read more Featured Media Sickle cell cures are coming. African children can’t be left behind 12 July 2023 Media Poor countries desperately need better access to generic medicines 15 February 2023 News Joint roundtable with Chatham House identifies key opportunities for expanding access to medical oxygen 12 December 2022 Achievements so far Read more about the Foundation's impact Event Closing the gaps in access to diabetes care in low- and middle-income countries 07 July 2022 News Global oxygen suppliers commit to closing oxygen gaps in low- and middle-income countries 16 June 2021